1. Home
  2. DAWN vs MRC Comparison

DAWN vs MRC Comparison

Compare DAWN & MRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAWN
  • MRC
  • Stock Information
  • Founded
  • DAWN 2018
  • MRC 1921
  • Country
  • DAWN United States
  • MRC United States
  • Employees
  • DAWN N/A
  • MRC N/A
  • Industry
  • DAWN Biotechnology: Pharmaceutical Preparations
  • MRC Industrial Machinery/Components
  • Sector
  • DAWN Health Care
  • MRC Industrials
  • Exchange
  • DAWN Nasdaq
  • MRC Nasdaq
  • Market Cap
  • DAWN 1.2B
  • MRC 1.2B
  • IPO Year
  • DAWN 2021
  • MRC 2012
  • Fundamental
  • Price
  • DAWN $8.07
  • MRC $11.63
  • Analyst Decision
  • DAWN Strong Buy
  • MRC Strong Buy
  • Analyst Count
  • DAWN 7
  • MRC 3
  • Target Price
  • DAWN $32.29
  • MRC $16.00
  • AVG Volume (30 Days)
  • DAWN 1.3M
  • MRC 818.7K
  • Earning Date
  • DAWN 05-05-2025
  • MRC 03-14-2025
  • Dividend Yield
  • DAWN N/A
  • MRC N/A
  • EPS Growth
  • DAWN N/A
  • MRC N/A
  • EPS
  • DAWN N/A
  • MRC 0.30
  • Revenue
  • DAWN $131,161,000.00
  • MRC $3,011,000,000.00
  • Revenue This Year
  • DAWN $28.72
  • MRC $7.31
  • Revenue Next Year
  • DAWN $73.78
  • MRC $5.73
  • P/E Ratio
  • DAWN N/A
  • MRC $38.34
  • Revenue Growth
  • DAWN N/A
  • MRC N/A
  • 52 Week Low
  • DAWN $7.88
  • MRC $9.42
  • 52 Week High
  • DAWN $18.07
  • MRC $15.41
  • Technical
  • Relative Strength Index (RSI)
  • DAWN 36.05
  • MRC 42.21
  • Support Level
  • DAWN $7.93
  • MRC $11.87
  • Resistance Level
  • DAWN $8.44
  • MRC $12.28
  • Average True Range (ATR)
  • DAWN 0.44
  • MRC 0.49
  • MACD
  • DAWN 0.09
  • MRC 0.08
  • Stochastic Oscillator
  • DAWN 17.59
  • MRC 70.83

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

About MRC MRC Global Inc.

MRC Global Inc distributes pipes, valves, fittings, and related products and services to the energy industry. Products are often used in the construction, maintenance, repair, and overhaul of equipment used in extreme operating conditions. In these conditions and other environments, MRC's valve products give the customer the ability to control the direction, velocity, and pressure of fluids and gases within transmission networks. In addition, other products can be used to regulate flow and on/off service. MRC's other products, which include pipe, steel fitting, and tubular goods, are used across all of the industries in which the company operates. Specialized services are delivered alongside this array of products to enhance the client relationship.

Share on Social Networks: